Convalescent plasma transfusion for the treatment of COVID‐19: Systematic review
- 12 May 2020
- journal article
- review article
- Published by Wiley in Journal of Medical Virology
- Vol. 92 (9), 1475-1483
- https://doi.org/10.1002/jmv.25961
Abstract
Background The recent emergence of COVID‐19 pandemic has reassessed the usefulness of historic convalescent plasma transfusion (CPT). This review was conducted to evaluate the effectiveness of CPT therapy in COVID‐19 patients based on the publications reported till date. To our knowledge, this is the first systematic review on convalescent plasma on clinically relevant outcomes in individuals with COVID‐19. Methods PubMed, EMBASE and Medline databases were searched upto 19 April 2020. All records were screened as per the protocol eligibility criteria. Results We included 5 studies reporting CPT to COVID‐19 patients. The main findings from available data are as follows: (1) Convalescent plasma may reduce mortality in critically ill patients (2) Increase in neutralizing antibody titers and disappearance of SARS‐CoV‐2 RNA was observed in almost all the patients after CPT therapy (3) Beneficial effect on clinical symptoms after administration of convalescent plasma. Conclusions Based on the limited scientific data, CPT therapy in COVID‐19 patient appears safe, clinically effective and reduces mortality. Well‐designed large multi center clinical trial studies should be conducted urgently to establish the efficacy of CPT to COVID‐19 patients.This publication has 15 references indexed in Scilit:
- Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent PlasmaJAMA, 2020
- Treatment With Convalescent Plasma for Critically Ill Patients With Severe Acute Respiratory Syndrome Coronavirus 2 InfectionSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2020
- Zirconocene-mediated selective synthesis of 1,4-bis(alkynyl)benzenesJournal of Chemical Research, 2020
- The convalescent sera option for containing COVID-19JCI Insight, 2020
- Potential interventions for novel coronavirus in China: A systematic reviewJournal of Medical Virology, 2020
- Convalescent Plasma Treatment Reduced Mortality in Patients With Severe Pandemic Influenza A (H1N1) 2009 Virus InfectionClinical Infectious Diseases, 2011
- Treatment with Convalescent Plasma for Influenza A (H5N1) InfectionThe New England Journal of Medicine, 2007
- Meta-Analysis: Convalescent Blood Products for Spanish Influenza Pneumonia: A Future H5N1 Treatment?Annals of Internal Medicine, 2006
- Use of convalescent plasma therapy in SARS patients in Hong KongEuropean Journal of Clinical Microbiology & Infectious Diseases, 2004
- Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patientsClinical Microbiology & Infection, 2004